This article is freely available to all

Article Abstract

Exciting new developments in the neurobiology of obsessive-compulsive disorder (OCD) and related disorders have emerged in the past few years, said Michael A. Jenike, M.D., chairperson of the symposium. The combination of advanced neuroimaging techniques along with collaboration between clinicians and researchers has contributed to greater understanding of the clinical implications as they relate to biological issues, he said. Dr. Jenike and fellow symposium presenters gathered to discuss the latest findings in neuroimaging, neuropsychology, and pharmacology and designed the conference to address the neurobiological and clinical implications of OCD, rather than the comprehensive treatment modalities for this disorder.